相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study
Anne Rossel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Feasibility of a human factors work-system designed recruitment method for hospitalized persons with dementia
Julia A. Loosen et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity
Vered Daitch et al.
BMC INFECTIOUS DISEASES (2021)
Using Charlson Comorbidity Index to Predict Short-Term Clinical Outcomes in Hospitalized Older Adults
Liron Sinvani et al.
JOURNAL FOR HEALTHCARE QUALITY (2019)
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
Dafna Yahav et al.
CLINICAL INFECTIOUS DISEASES (2019)
Procedural Framework to Facilitate Hospital-Based Informed Consent for Dementia Research
Timothy R. Holden et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network
Ryoko Susukida et al.
ADDICTION (2016)
New ICD-10 version of the Multipurpose Australian Comorbidity Scoring System outperformed Charlson and Elixhauser comorbidities in an older population
Barbara Toson et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
Tessa Kennedy-Martin et al.
TRIALS (2015)
External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA
Mical Paul et al.
BMJ OPEN (2015)
Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study
Annemarije L. Kruis et al.
PLOS ONE (2014)
External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?
C. Saunders et al.
DIABETIC MEDICINE (2013)
Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs
Cecile Konrat et al.
PLOS ONE (2012)
Exclusion of Older People from Clinical Trials Professional Views from Nine European Countries Participating in the PREDICT Study
Peter Crome et al.
DRUGS & AGING (2011)
Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention
Chiara Melloni et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Surrogate consent for research involving adults with impaired decision making: Survey of Institutional Review Board practices
Michelle Ng Gong et al.
CRITICAL CARE MEDICINE (2010)
Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?
Justin Travers et al.
THORAX (2007)
Participation in cancer clinical trials - Race-, sex-, and age-based disparities
VH Murthy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Representation of elderly persons and women in published randomized trials of acute coronary syndromes
PY Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
